早老性的痴呆药物研究进展.pptVIP

  • 0
  • 0
  • 约6.31千字
  • 约 26页
  • 2018-12-17 发布于福建
  • 举报
早老性的痴呆药物研究进展

How to accelerate AD research Contents 1 Current situation of AD Population:37 million Causes:too sophisticated Market drugs:Tarcrine,Donepezil,Rivastigmine,Galanthamine,Huperzine,Memantine Some social activities may correlate with AD,but cannot delay the progress of AD 2 What are big companies doing A big cake attracts a lot of big companies,attention,such as Pfizer,Elan,Merk,Novartis and so on BMC Medicine 2009, 7:7 Tramiprosate ALZHEMED(Neurochem

文档评论(0)

1亿VIP精品文档

相关文档